Imagene (@imagene_ai) 's Twitter Profile
Imagene

@imagene_ai

AI-based Molecular Profiling for Cancer

ID: 1234065972560003072

linkhttp://imagene-ai.com calendar_today01-03-2020 10:40:44

98 Tweet

1,1K Followers

1,1K Following

Imagene (@imagene_ai) 's Twitter Profile Photo

Congratulation to Prof. D. Ross Camidge, our distinguish Scientific Advisor, for the well-deserved Leadership Award for Medical Oncology at #WCLC2023 #IASLC

Congratulation to Prof. D. Ross Camidge, our distinguish Scientific Advisor, for the well-deserved Leadership Award for Medical Oncology at #WCLC2023 #IASLC
Imagene (@imagene_ai) 's Twitter Profile Photo

We are proud to be selected as a Finalist for #DigitalHealthAwards 2023 for the “Best Use of AI In Health Tech”. Being recognized as a Finalist is a true honor, we are thankful to our hardworking team for their commitment, innovative thinking and uncompromising dedication.

We are proud to be selected as a Finalist for #DigitalHealthAwards 2023 for the “Best Use of AI In Health Tech”. Being recognized as a Finalist is a true honor, we are thankful to our hardworking team for their commitment, innovative thinking and uncompromising dedication.
Imagene (@imagene_ai) 's Twitter Profile Photo

We’re live at #PathologyVisions23 in Orlando, come to visit us at booth #406 and join us for an enlightening session on "Immediate Image-Based Molecular Profiling" with Addie Dvir, MSc, Head of Diagnostics - October 31st at 12:55pm #DigitalPathology #MolecularPathology

We’re live at #PathologyVisions23 in Orlando, come to visit us at booth #406 and join us for an enlightening session on "Immediate Image-Based Molecular Profiling" with Addie Dvir, MSc, Head of Diagnostics - October 31st at 12:55pm
#DigitalPathology #MolecularPathology
Imagene (@imagene_ai) 's Twitter Profile Photo

Our newly paper in @Cancers_MDP showcase an AI-based methodology that can detect double/triple-hit events using only the diagnostic WSI. Showing the potential of rapid AI analysis in supporting the diagnosis process in hematopathology. mdpi.com/2072-6694/15/2…

Imagene (@imagene_ai) 's Twitter Profile Photo

November is #LungCancerAwarenessMonth Awareness and education play pivotal roles in saving lives. Just as crucially is understanding the unique drivers behind each patient's cancer and tailoring therapy to the individual makeup of their tumor #moleculartesting #precisiononcology

November is #LungCancerAwarenessMonth
Awareness and education play pivotal roles in saving lives. Just as crucially is understanding the unique drivers behind each patient's cancer and tailoring therapy to the individual makeup of their tumor
#moleculartesting #precisiononcology
Imagene (@imagene_ai) 's Twitter Profile Photo

Happy to start 2024 at #JPM2024 where innovation meet healthcare leadership. Dean bitan our Co-founder & CEO would be happy to meet and discuss how Immediate Oncology Intelligence can transform cancer diagnosis and care. DM or schedule a meeting meetings.hubspot.com/dean-bitan/jp-…

Happy to start 2024 at #JPM2024 where innovation meet healthcare leadership. <a href="/DeanBitan/">Dean bitan</a> our Co-founder &amp; CEO would be happy to meet and discuss how Immediate Oncology Intelligence can transform cancer diagnosis and care. DM or schedule a meeting meetings.hubspot.com/dean-bitan/jp-…
Imagene (@imagene_ai) 's Twitter Profile Photo

Honor to be selected as one of the Top 20 Promising Precision Medicine Startups. StartUs Insights conducted an in-depth research on the Top 10 Trends in Precision Medicine and analyzed ~1700 global startups & scaleups with technologies that revolutionizes pharma and healthcare.

Imagene (@imagene_ai) 's Twitter Profile Photo

Happy to announce the availability of ImageneOI, the first NSCLC genomic profiling AI tool on the Sectra Marketplace. Healthcare providers can seamlessly access and use rapid AI-based NSCLC biomarker profiling newswire.com/news/imagene-i… #digitalpathology Sectra

Imagene (@imagene_ai) 's Twitter Profile Photo

#ASCO2024 is less than a month away. We will be showcasing the latest advancements in AI-based biomarker profiling solutions, stop by and meet us at Booth #10064. Schedule a meeting in advance: meetings.hubspot.com/daniel-shiri/a…

#ASCO2024 is less than a month away.
We will be showcasing the latest advancements in AI-based biomarker profiling solutions, stop by and meet us at Booth #10064.
Schedule a meeting in advance: meetings.hubspot.com/daniel-shiri/a…
Imagene (@imagene_ai) 's Twitter Profile Photo

Some of our esteemed advisors have established a new reporting standards for NGS results in NSCLC. Congrats to Christian Rolfo @NatashaLeighl, Nir peled Dov Hershkovitz @MaximilianHochmair, and their collaborators on this significant achievement! nature.com/articles/s4141…

Imagene (@imagene_ai) 's Twitter Profile Photo

We're excited to share the culmination of key milestones of our flag ship product LungOI - CLIA certification, LDT product launch, and Medicare code and rate. newswire.com/news/imagene-a…

We're excited to share the culmination of key milestones of our flag ship product LungOI - CLIA certification, LDT product launch, and Medicare code and rate. 
newswire.com/news/imagene-a…
The James (@osuccc_james) 's Twitter Profile Photo

We're thrilled to announce that Christian Rolfo, MD, PhD, will join The James team as director of our Division of Medical #Oncology. Welcome to #BuckeyeNation Dr. Rolfo! cancer.osu.edu/news/ohio-stat…

Imagene (@imagene_ai) 's Twitter Profile Photo

Congratulations to Christian Rolfo on his appointment as Director of the Division of Medical Oncology at OSUCCC. Proud to have such an accomplished leader on Imagene scientific advisory board. Your contributions to oncology continue to inspire us all! cancer.osu.edu/news/ohio-stat…

Imagene (@imagene_ai) 's Twitter Profile Photo

Imagene, Oracle and @EITLosAngeles unveil CanvOI: a state-of-the-art vision #foundationmodel, providing diagnostics developers and researchers an innovative tool in the fight against #cancer oracle.com/news/announcem… David Agus Larry Ellison #OCI #OncologyIntelligence

Imagene, <a href="/Oracle/">Oracle</a> and @EITLosAngeles unveil CanvOI: a state-of-the-art vision #foundationmodel, providing diagnostics developers and researchers an innovative tool in the fight against #cancer 
oracle.com/news/announcem… 
<a href="/DavidAgus/">David Agus</a> <a href="/larryellison/">Larry Ellison</a> #OCI #OncologyIntelligence
Imagene (@imagene_ai) 's Twitter Profile Photo

We are pleased to announce our collaboration with Tempus to advance AI-powered diagnostics for non-small cell lung cancer (NSCLC). newswire.com/news/imagene-a… Tempus

We are pleased to announce our collaboration with Tempus to advance AI-powered diagnostics for non-small cell lung cancer (NSCLC). newswire.com/news/imagene-a…
<a href="/TempusAI/">Tempus</a>
Tempus (@tempusai) 's Twitter Profile Photo

We're excited to announce a collaboration with Imagene to advance #AI-driven diagnostics for non-small cell lung cancer. Learn more: tempus.co/imagenecollabo… #NSCLC

We're excited to announce a collaboration with <a href="/Imagene_ai/">Imagene</a> to advance #AI-driven diagnostics for non-small cell lung cancer. Learn more: tempus.co/imagenecollabo… #NSCLC
Imagene (@imagene_ai) 's Twitter Profile Photo

We’re proud to share that Imagene has been named the winner of the Innovation Award in Precision Oncology at the 2025 Pharmaceutical Technology Excellence Awards. pharmaceutical-technology.com/excellence-awa…